MRI developer Magna-Lab willenjoy its first RSNA meeting with Food and Drug Administrationclearance for its Magna-SL scanner, a small-bore 0.3-tesla permanentmagnet scanner for niche applications. The Hicksville, NY-basedcompany received FDA clearance
MRI developer Magna-Lab willenjoy its first RSNA meeting with Food and Drug Administrationclearance for its Magna-SL scanner, a small-bore 0.3-tesla permanentmagnet scanner for niche applications. The Hicksville, NY-basedcompany received FDA clearance in September (SCAN 9/28/94).
Magna-Lab is marketing Magna-SL as a cost-effective scannerfor novel applications such as extremity scans of weight-bearingknees. The scanner has a list price of about $500,000 and sitesin 150 square feet of space.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.